Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction

Citation
Y. Okamoto et al., Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction, AM J PATH, 159(2), 2001, pp. 639-650
Citations number
43
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
159
Issue
2
Year of publication
2001
Pages
639 - 650
Database
ISI
SICI code
0002-9440(200108)159:2<639:TMWCEO>2.0.ZU;2-L
Abstract
Activating transcription factor 3 (ATF3) is a member of the CREB/ATF family of transcription factors. Previously, we demonstrated that the expression of the ATF3 gene is induced by many stress signals. In this report, we demo nstrate that expression of ATF3 is induced by cardiac ischemia coupled with reperfusion (ischemia-reperfusion) in both cultured cells and an animal mo del. Transgenic mice expressing ATF3 under the control of the alpha -myosin heavy chain promoter have atrial enlargement, and atrial and ventricular h ypertrophy. Microscopic examination showed myocyte degeneration and fibrosi s. Functionally, the transgenic heart has reduced contractility and aberran t conduction. Interestingly, expression of sorcin, a gene whose product inh ibits the release of calcium from sarcoplasmic reticulum, is increased in t hese transgenic hearts. Taken together, our results indicate that expressio n of ATF3, a stress-inducible gene, in the heart leads to altered gene expr ession and impaired cardiac function.